Patent 10590206 was granted and assigned to Genmab A/S on March, 2020 by the United States Patent and Trademark Office.
Described herein are, proteins comprising amino acid substitutions in at least one of a first and a second polypeptide chain. Furthermore, is described the uses and methods related to said proteins.